Is teicoplanin a complementary treatment option for COVID-19? The question remains.
Int J Antimicrob Agents
; 56(2): 106029, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-343720
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Teicoplanin
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Int J Antimicrob Agents
Year:
2020
Document Type:
Article
Affiliation country:
J.ijantimicag.2020.106029
Similar
MEDLINE
...
LILACS
LIS